Статті в журналах з теми "HIV vaccine; adjuvants"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "HIV vaccine; adjuvants".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Berendam, Stella J., Papa K. Morgan-Asiedu, Riley J. Mangan, Shuk Hang Li, Holly Heimsath, Kan Luo, Alan D. Curtis, et al. "Different adjuvanted pediatric HIV envelope vaccines induced distinct plasma antibody responses despite similar B cell receptor repertoires in infant rhesus macaques." PLOS ONE 16, no. 12 (December 31, 2021): e0256885. http://dx.doi.org/10.1371/journal.pone.0256885.
Повний текст джерелаMoser, B. A., R. C. Steinhardt, Y. Escalante-Buendia, D. A. Boltz, K. M. Barker, B. J. Cassaidy, M. G. Rosenberger, S. Yoo, B. G. McGonnigal та A. P. Esser-Kahn. "Increased vaccine tolerability and protection via NF-κB modulation". Science Advances 6, № 37 (вересень 2020): eaaz8700. http://dx.doi.org/10.1126/sciadv.aaz8700.
Повний текст джерелаKozlowski, Pamela A., and Anna Aldovini. "Mucosal Vaccine Approaches for Prevention of HIV and SIV Transmission." Current Immunology Reviews 15, no. 1 (April 12, 2019): 102–22. http://dx.doi.org/10.2174/1573395514666180605092054.
Повний текст джерелаLouis, Lumena, Megan C. Wise, Hyeree Choi, Daniel O. Villarreal, Kar Muthumani, and David B. Weiner. "Designed DNA-Encoded IL-36 Gamma Acts as a Potent Molecular Adjuvant Enhancing Zika Synthetic DNA Vaccine-Induced Immunity and Protection in a Lethal Challenge Model." Vaccines 7, no. 2 (May 22, 2019): 42. http://dx.doi.org/10.3390/vaccines7020042.
Повний текст джерелаOzorowski, Gabriel, Albert Cupo, Michael Golabek, Michelle LoPiccolo, Thomas A. Ketas, Matt Cavallary, Christopher A. Cottrell, P. J. Klasse, Andrew B. Ward, and John P. Moore. "Effects of Adjuvants on HIV-1 Envelope Glycoprotein SOSIP TrimersIn Vitro." Journal of Virology 92, no. 13 (April 18, 2018): e00381-18. http://dx.doi.org/10.1128/jvi.00381-18.
Повний текст джерелаGupta, Sachin, Emily S. Clark, James M. Termini, Justin Boucher, Saravana Kanagavelu, Celia C. LeBranche, Sakhi Abraham, David C. Montefiori, Wasif N. Khan, and Geoffrey W. Stone. "DNA Vaccine Molecular Adjuvants SP-D-BAFF and SP-D-APRIL Enhance Anti-gp120 Immune Response and Increase HIV-1 Neutralizing Antibody Titers." Journal of Virology 89, no. 8 (January 28, 2015): 4158–69. http://dx.doi.org/10.1128/jvi.02904-14.
Повний текст джерелаCeglia, Valentina, Sandy Zurawski, Monica Montes, Aurelie Bouteau, Zhiqing Wang, Jerome Ellis, Mitchell Kroll, Botond Z. Igyarto, Yves Levy, and Gerard Zurawski. "Dendritic cell targeting anti-CD40 antibody-CD40L-HIV-1 vaccines are adjuvant intrinsic." Journal of Immunology 204, no. 1_Supplement (May 1, 2020): 167.2. http://dx.doi.org/10.4049/jimmunol.204.supp.167.2.
Повний текст джерелаBui, Cac T., Lisa M. Shollenberger, Yvonne Paterson, and Donald A. Harn. "Schistosoma mansoni Soluble Egg Antigens Enhance Listeria monocytogenes Vector HIV-1 Vaccine Induction of Cytotoxic T Cells." Clinical and Vaccine Immunology 21, no. 9 (July 2, 2014): 1232–39. http://dx.doi.org/10.1128/cvi.00138-14.
Повний текст джерелаShollenberger, Lisa M., Stephanie K. Norwood, and Zachary J. Bement. "Development of alternative vaccination strategies to overcome Tc1 vaccine failure caused by chronic schistosomiasis." Journal of Immunology 204, no. 1_Supplement (May 1, 2020): 167.13. http://dx.doi.org/10.4049/jimmunol.204.supp.167.13.
Повний текст джерелаVijayan, Mohapatra, Uthaman, and Park. "Recent Advances in Nanovaccines Using Biomimetic Immunomodulatory Materials." Pharmaceutics 11, no. 10 (October 14, 2019): 534. http://dx.doi.org/10.3390/pharmaceutics11100534.
Повний текст джерелаGómez, Carmen Elena, Beatriz Perdiguero, Michela Falqui, María Q. Marín, Martina Bécares, Carlos Óscar S. Sorzano, Juan García-Arriaza, Mariano Esteban, and Susana Guerra. "Enhancement of HIV-1 Env-Specific CD8 T Cell Responses Using Interferon-Stimulated Gene 15 as an Immune Adjuvant." Journal of Virology 95, no. 2 (October 28, 2020): e01155-20. http://dx.doi.org/10.1128/jvi.01155-20.
Повний текст джерелаBuglione-Corbett, Rachel, Kim Pouliot, Robyn Marty-Roix, Kim West, Shixia Wang, Egil Lien, and Shan Lu. "Adjuvant-dependent cytokine profiles in the context of a DNA prime-protein boost HIV vaccine (113.23)." Journal of Immunology 188, no. 1_Supplement (May 1, 2012): 113.23. http://dx.doi.org/10.4049/jimmunol.188.supp.113.23.
Повний текст джерелаCheng, Liang, Guangming Li, Dan Li, Zheng Zhang, Feng Li, Sandra Zurawski, Gerard Zurawski, Yves Levy, and Lishan Su. "A novel therapeutic vaccination delays cART-resistant HIV-1 reservoir rebound in HIV-1 infected humanized mice." Journal of Immunology 196, no. 1_Supplement (May 1, 2016): 76.7. http://dx.doi.org/10.4049/jimmunol.196.supp.76.7.
Повний текст джерелаLaher, Fatima, Linda-Gail Bekker, Nigel Garrett, Erica M. Lazarus, and Glenda E. Gray. "Review of preventative HIV vaccine clinical trials in South Africa." Archives of Virology 165, no. 11 (August 14, 2020): 2439–52. http://dx.doi.org/10.1007/s00705-020-04777-2.
Повний текст джерелаKutzler, Michele, Noshin Kathuria, Ashley Curatola, Getrude Makurumidze, Devon Myles, Kar Muthumani, Albert Sylvester, et al. "CCR10 expression is required for immunogenicity of a HIV-1env DNA vaccine encoding CCL28 to enhance HIV-1env-specific IgG and IgA at relevant mucosal sites (VAC7P.986)." Journal of Immunology 192, no. 1_Supplement (May 1, 2014): 141.31. http://dx.doi.org/10.4049/jimmunol.192.supp.141.31.
Повний текст джерелаBement, Zachary James, Stephanie K. Norwood, and Lisa M. Shollenberger. "Understanding the early steps of the adaptive immune response to differentially-effective vaccines during chronic schistosomiasis." Journal of Immunology 204, no. 1_Supplement (May 1, 2020): 167.14. http://dx.doi.org/10.4049/jimmunol.204.supp.167.14.
Повний текст джерелаKilgore, Katie M., Megan K. Murphy, Samantha L. Burton, Katherine S. Wetzel, S. Abigail Smith, Peng Xiao, Sharmila Reddy, et al. "Characterization and Implementation of a Diverse Simian Immunodeficiency Virus SIVsm Envelope Panel in the Assessment of Neutralizing Antibody Breadth Elicited in Rhesus Macaques by Multimodal Vaccines Expressing the SIVmac239 Envelope." Journal of Virology 89, no. 16 (May 27, 2015): 8130–51. http://dx.doi.org/10.1128/jvi.01221-14.
Повний текст джерелаCasimiro, Danilo R., Ling Chen, Tong-Ming Fu, Robert K. Evans, Michael J. Caulfield, Mary-Ellen Davies, Aimin Tang, et al. "Comparative Immunogenicity in Rhesus Monkeys of DNA Plasmid, Recombinant Vaccinia Virus, and Replication-Defective Adenovirus Vectors Expressing a Human Immunodeficiency Virus Type 1 gag Gene." Journal of Virology 77, no. 11 (June 1, 2003): 6305–13. http://dx.doi.org/10.1128/jvi.77.11.6305-6313.2003.
Повний текст джерелаDíaz-Dinamarca, Diego A., Michelle L. Salazar, Byron N. Castillo, Augusto Manubens, Abel E. Vasquez, Fabián Salazar, and María Inés Becker. "Protein-Based Adjuvants for Vaccines as Immunomodulators of the Innate and Adaptive Immune Response: Current Knowledge, Challenges, and Future Opportunities." Pharmaceutics 14, no. 8 (August 11, 2022): 1671. http://dx.doi.org/10.3390/pharmaceutics14081671.
Повний текст джерелаStaats, Herman F., and Francis A. Ennis. "IL-1 Is an Effective Adjuvant for Mucosal and Systemic Immune Responses When Coadministered with Protein Immunogens." Journal of Immunology 162, no. 10 (May 15, 1999): 6141–47. http://dx.doi.org/10.4049/jimmunol.162.10.6141.
Повний текст джерелаWilson, Cara C., Walter C. Olson, Thomas Tuting, Charles R. Rinaldo, Michael T. Lotze, and Walter J. Storkus. "HIV-1-Specific CTL Responses Primed In Vitro by Blood-Derived Dendritic Cells and Th1-Biasing Cytokines." Journal of Immunology 162, no. 5 (March 1, 1999): 3070–78. http://dx.doi.org/10.4049/jimmunol.162.5.3070.
Повний текст джерелаWille-Reece, Ulrike, Barbara J. Flynn, Karin Loré, Richard A. Koup, Aaron P. Miles, Allan Saul, Ross M. Kedl, et al. "Toll-like receptor agonists influence the magnitude and quality of memory T cell responses after prime-boost immunization in nonhuman primates." Journal of Experimental Medicine 203, no. 5 (April 24, 2006): 1249–58. http://dx.doi.org/10.1084/jem.20052433.
Повний текст джерелаChamcha, Venkateswarlu, Pradeep B. J. Reddy, Sunil Kannanganat, Courtney Wilkins, Sailaja Gangadhara, Vijayakumar Velu, Richard Green, et al. "Strong TH1-biased CD4 T cell responses are associated with diminished SIV vaccine efficacy." Science Translational Medicine 11, no. 519 (November 20, 2019): eaav1800. http://dx.doi.org/10.1126/scitranslmed.aav1800.
Повний текст джерелаTunggal, Hillary Claire, Paul Veness Munson, Megan Ashley O’Connor, Nika Hajari, Sandra Elizabeth Dross, Debra Bratt, James Thomas Fuller, Kenneth Bagley, and Deborah Heydenburg Fuller. "Effects of therapeutic vaccination on the control of SIV in rhesus macaques with variable responsiveness to antiretroviral drugs." PLOS ONE 16, no. 6 (June 17, 2021): e0253265. http://dx.doi.org/10.1371/journal.pone.0253265.
Повний текст джерелаMatchett, William E., Goda Baddage Rakitha Malewana, Haley Mudrick, Michael J. Medlyn, and Michael A. Barry. "Genetic Adjuvants in Replicating Single-Cycle Adenovirus Vectors Amplify Systemic and Mucosal Immune Responses against HIV-1 Envelope." Vaccines 8, no. 1 (February 2, 2020): 64. http://dx.doi.org/10.3390/vaccines8010064.
Повний текст джерелаAKAGI, Takami, Masanori BABA, and Mitsuru AKASHI. "Development of Vaccine Adjuvants Using Polymeric Nanoparticles and Their Potential Applications for Anti-HIV Vaccine." YAKUGAKU ZASSHI 127, no. 2 (February 1, 2007): 307–17. http://dx.doi.org/10.1248/yakushi.127.307.
Повний текст джерелаMelo, Alanne Rayssa da Silva, Larissa Silva de Macêdo, Maria da Conceição Viana Invenção, Ingrid Andrêssa de Moura, Marco Antonio Turiah Machado da Gama, Cristiane Moutinho Lagos de Melo, Anna Jéssica Duarte Silva, Marcus Vinicius de Aragão Batista, and Antonio Carlos de Freitas. "Third-Generation Vaccines: Features of Nucleic Acid Vaccines and Strategies to Improve Their Efficiency." Genes 13, no. 12 (December 4, 2022): 2287. http://dx.doi.org/10.3390/genes13122287.
Повний текст джерелаSundling, Christopher, Karin Schön, Andreas Mörner, Mattias N. E. Forsell, Richard T. Wyatt, Rigmor Thorstensson, Gunilla B. Karlsson Hedestam, and Nils Y. Lycke. "CTA1-DD adjuvant promotes strong immunity against human immunodeficiency virus type 1 envelope glycoproteins following mucosal immunization." Journal of General Virology 89, no. 12 (December 1, 2008): 2954–64. http://dx.doi.org/10.1099/vir.0.2008/005470-0.
Повний текст джерелаShollenberger, Lisa M., and Donald A. Harn. "Vaccine self-assembling immune matrix is a non-viral delivery platform that improves overall vaccine performance while maintaining safety and stability." Journal of Immunology 198, no. 1_Supplement (May 1, 2017): 147.2. http://dx.doi.org/10.4049/jimmunol.198.supp.147.2.
Повний текст джерелаGary, Ebony N., and Michele A. Kutzler. "Defensive Driving: Directing HIV-1 Vaccine-Induced Humoral Immunity to the Mucosa with Chemokine Adjuvants." Journal of Immunology Research 2018 (December 13, 2018): 1–14. http://dx.doi.org/10.1155/2018/3734207.
Повний текст джерелаDecroix, Nipa, Perayot Pamonsinlapatham, Cahn P. Quan, and Jean-Pierre Bouvet. "Impairment by Mucosal Adjuvants and Cross-Reactivity with Variant Peptides of the Mucosal Immunity Induced by Injection of the Fusion Peptide PADRE-ELDKWA." Clinical Diagnostic Laboratory Immunology 10, no. 6 (November 2003): 1103–8. http://dx.doi.org/10.1128/cdli.10.6.1103-1108.2003.
Повний текст джерелаStone, Geoffrey W., Suzanne Barzee, Victoria Snarsky, Celsa A. Spina, Jeffrey D. Lifson, Vinod Kumar Bhaskara Pillai, Rama Rao Amara, François Villinger, and Richard S. Kornbluth. "Macaque Multimeric Soluble CD40 Ligand and GITR Ligand Constructs Are Immunostimulatory Molecules In Vitro." Clinical and Vaccine Immunology 13, no. 11 (September 20, 2006): 1223–30. http://dx.doi.org/10.1128/cvi.00198-06.
Повний текст джерелаCourtney, Amy N., Prakash Thapa, Pramod N. Nehete, Chun Li, Dapeng Zhou та K. Jagannadha Sastry. "α-GalCer is an effective mucosal adjuvant for repeated nasal or oral delivery of HIV peptide antigens (39.54)". Journal of Immunology 182, № 1_Supplement (1 квітня 2009): 39.54. http://dx.doi.org/10.4049/jimmunol.182.supp.39.54.
Повний текст джерелаLeroy, Laury-Anne, Alice Mac Donald, Aditi Kandlur, Deepanwita Bose, Peng Xiao, Jean Gagnon, François Villinger, and Yahia Chebloune. "Cytokine Adjuvants IL-7 and IL-15 Improve Humoral Responses of a SHIV LentiDNA Vaccine in Animal Models." Vaccines 10, no. 3 (March 17, 2022): 461. http://dx.doi.org/10.3390/vaccines10030461.
Повний текст джерелаChapman, Rosamund, and Edward P. Rybicki. "Use of a Novel Enhanced DNA Vaccine Vector for Preclinical Virus Vaccine Investigation." Vaccines 7, no. 2 (June 13, 2019): 50. http://dx.doi.org/10.3390/vaccines7020050.
Повний текст джерелаCostiniuk, Cecilia T., Joel Singer, Marc-André Langlois, Iva Kulic, Judy Needham, Ann Burchell, Mohammad-Ali Jenabian, et al. "CTN 328: immunogenicity outcomes in people living with HIV in Canada following vaccination for COVID-19 (HIV-COV): protocol for an observational cohort study." BMJ Open 11, no. 12 (December 2021): e054208. http://dx.doi.org/10.1136/bmjopen-2021-054208.
Повний текст джерелаDanilenko, V. N. "Development of a technological platfom for creating innovative anti-tb drugs effective against multi-drug-resistant strains." Вестник Российской академии наук 89, no. 5 (May 6, 2019): 427–35. http://dx.doi.org/10.31857/s0869-5873895427-435.
Повний текст джерелаBoopathy, Archana Vidya, Anasuya Mandal, Dan W. Kulp, Sudha Kumari, Wade Wang, Yanpu He, Talar Tokatlian, William R. Schief, Paula T. Hammond, and Darrell J. Irvine. "Sustained delivery of a HIV subunit vaccine using silk microneedle skin patches." Journal of Immunology 198, no. 1_Supplement (May 1, 2017): 225.22. http://dx.doi.org/10.4049/jimmunol.198.supp.225.22.
Повний текст джерелаde Jong, Wesley, Lorna Leal, Jozefien Buyze, Pieter Pannus, Alberto Guardo, Maria Salgado, Beatriz Mothe, et al. "Therapeutic Vaccine in Chronically HIV-1-Infected Patients: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Trial with HTI-TriMix." Vaccines 7, no. 4 (December 6, 2019): 209. http://dx.doi.org/10.3390/vaccines7040209.
Повний текст джерелаGreslehner, Gregor P. "The vaccinologist’s “dirty little secret”: a better understanding of structure-function relationships of viral immunogens might advance rational HIV vaccine design." Archives of Virology 166, no. 5 (February 19, 2021): 1297–303. http://dx.doi.org/10.1007/s00705-021-04982-7.
Повний текст джерелаLi, Y., K. Svehla, N. L. Mathy, G. Voss, J. R. Mascola, and R. Wyatt. "Characterization of Antibody Responses Elicited by Human Immunodeficiency Virus Type 1 Primary Isolate Trimeric and Monomeric Envelope Glycoproteins in Selected Adjuvants." Journal of Virology 80, no. 3 (February 1, 2006): 1414–26. http://dx.doi.org/10.1128/jvi.80.3.1414-1426.2006.
Повний текст джерелаReale, Marcella, Claudio Ucciferri, Erica Costantini, Marta Di Nicola, Annamaria Porreca, Pamela Di Giovanni, Michela Pontolillo, Antonio Auricchio, Jacopo Vecchiet, and Katia Falasca. "Effects of Probiotic Mixture Supplementation on the Immune Response to the 13-Valent Pneumococcal Conjugate Vaccine in People Living with HIV." Nutrients 13, no. 12 (December 9, 2021): 4412. http://dx.doi.org/10.3390/nu13124412.
Повний текст джерелаLayton, G. T., S. J. Harris, A. J. Gearing, M. Hill-Perkins, J. S. Cole, J. C. Griffiths, N. R. Burns, A. J. Kingsman, and S. E. Adams. "Induction of HIV-specific cytotoxic T lymphocytes in vivo with hybrid HIV-1 V3:Ty-virus-like particles." Journal of Immunology 151, no. 2 (July 15, 1993): 1097–107. http://dx.doi.org/10.4049/jimmunol.151.2.1097.
Повний текст джерелаMooij, Petra, Sunita S. Balla-Jhagjhoorsingh, Niels Beenhakker, Patricia van Haaften, Ilona Baak, Ivonne G. Nieuwenhuis, Shirin Heidari, et al. "Comparison of Human and Rhesus Macaque T-Cell Responses Elicited by Boosting with NYVAC Encoding Human Immunodeficiency Virus Type 1 Clade C Immunogens." Journal of Virology 83, no. 11 (March 25, 2009): 5881–89. http://dx.doi.org/10.1128/jvi.02345-08.
Повний текст джерелаAbdelAllah, Nourhan H., Nourtan F. Abdeltawab, Abeer A. Boseila, and Magdy A. Amin. "Chitosan and Sodium Alginate Combinations Are Alternative, Efficient, and Safe Natural Adjuvant Systems for Hepatitis B Vaccine in Mouse Model." Evidence-Based Complementary and Alternative Medicine 2016 (2016): 1–8. http://dx.doi.org/10.1155/2016/7659684.
Повний текст джерелаKim, Jong J., Kenneth A. Simbiri, Jeong I. Sin, Kesen Dang, Jim Oh, Tzvete Dentchev, Daniel Lee, et al. "Cytokine Molecular Adjuvants Modulate Immune Responses Induced by DNA Vaccine Constructs for HIV-1 and SIV." Journal of Interferon & Cytokine Research 19, no. 1 (January 1999): 77–84. http://dx.doi.org/10.1089/107999099314441.
Повний текст джерелаTom, Janine, Tyler Albin, Amanda M. Burkhardt, Philip Felgner, and Aaron Esser-Kahn. "Development of a tri-agonist compound library used to determine optimal adjuvanticity of a Q fever vaccine." Journal of Immunology 196, no. 1_Supplement (May 1, 2016): 76.18. http://dx.doi.org/10.4049/jimmunol.196.supp.76.18.
Повний текст джерелаKanagavelu, Saravana K., Victoria Snarsky, James M. Termini, Sachin Gupta, Suzanne Barzee, Jacqueline A. Wright, Wasif N. Khan, Richard S. Kornbluth, and Geoffrey W. Stone. "Soluble multi-trimeric TNF superfamily ligand adjuvants enhance immune responses to a HIV-1 Gag DNA vaccine." Vaccine 30, no. 4 (January 2012): 691–702. http://dx.doi.org/10.1016/j.vaccine.2011.11.088.
Повний текст джерелаCheng, Liang, Zheng Zhang, Sandra Zurawski, Gerard Zurawski, Yves Levy, and Lishan Su. "Toll-like receptor ligands differentially activate human innate immune system and distinctively enhance antigen-specific T cell response to vaccination in humanized mice (VAC4P.1105)." Journal of Immunology 194, no. 1_Supplement (May 1, 2015): 72.10. http://dx.doi.org/10.4049/jimmunol.194.supp.72.10.
Повний текст джерелаLamrayah, Myriam, Capucine Phelip, Céline Coiffier, Céline Lacroix, Thibaut Willemin, Thomas Trimaille, and Bernard Verrier. "A Polylactide-Based Micellar Adjuvant Improves the Intensity and Quality of Immune Response." Pharmaceutics 14, no. 1 (January 3, 2022): 107. http://dx.doi.org/10.3390/pharmaceutics14010107.
Повний текст джерела